211 related articles for article (PubMed ID: 35640906)
1. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
[TBL] [Abstract][Full Text] [Related]
2. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Tan MMX; Malek N; Lawton MA; Hubbard L; Pittman AM; Joseph T; Hehir J; Swallow DMA; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Hardy J; Wood N; Ben-Shlomo Y; Grosset DG; Williams NM; Morris HR
Brain; 2019 Sep; 142(9):2828-2844. PubMed ID: 31324919
[TBL] [Abstract][Full Text] [Related]
4. Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.
Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
Mov Disord; 2023 Dec; 38(12):2249-2257. PubMed ID: 37926948
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Heterozygous PRKN Variants and Copy-Number Variations in Parkinson's Disease.
Yu E; Rudakou U; Krohn L; Mufti K; Ruskey JA; Asayesh F; Estiar MA; Spiegelman D; Surface M; Fahn S; Waters CH; Greenbaum L; Espay AJ; Dauvilliers Y; Dupré N; Rouleau GA; Hassin-Baer S; Fon EA; Alcalay RN; Gan-Or Z
Mov Disord; 2021 Jan; 36(1):178-187. PubMed ID: 32970363
[TBL] [Abstract][Full Text] [Related]
6. Identification of mutations in the PARK2 gene in Serbian patients with Parkinson's disease.
Jankovic MZ; Dobricic V; Kresojevic N; Markovic V; Petrovic I; Svetel M; Pekmezovic T; Novakovic I; Kostic V
J Neurol Sci; 2018 Oct; 393():27-30. PubMed ID: 30099245
[TBL] [Abstract][Full Text] [Related]
7. Long-read sequencing resolves a complex structural variant in
Daida K; Funayama M; Billingsley KJ; Malik L; Miano-Burkhardt A; Leonard HL; Makarious MB; Iwaki H; Ding J; Gibbs JR; Ishiguro M; Yoshino H; Ogaki K; Oyama G; Nishioka K; Nonaka R; Akamatsu W; Blauwendraat C; Hattori N
medRxiv; 2023 Aug; ():. PubMed ID: 37790330
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
Borsche M; König IR; Delcambre S; Petrucci S; Balck A; Brüggemann N; Zimprich A; Wasner K; Pereira SL; Avenali M; Deuschle C; Badanjak K; Ghelfi J; Gasser T; Kasten M; Rosenstiel P; Lohmann K; Brockmann K; Valente EM; Youle RJ; Grünewald A; Klein C
Brain; 2020 Oct; 143(10):3041-3051. PubMed ID: 33029617
[TBL] [Abstract][Full Text] [Related]
9. Genetic study of early-onset Parkinson's disease in the Malaysian population.
Tay YW; Tan AH; Lim JL; Lohmann K; Ibrahim KA; Abdul Aziz Z; Chin YT; Mawardi AS; Lim TT; Looi I; Chia YK; Ooi JCE; Cheah WK; Dy Closas AMF; Lit LC; Hor JW; Toh TS; Muthusamy KA; Bauer P; Skrahin V; Rolfs A; Klein C; Ahmad-Annuar A; Lim SY
Parkinsonism Relat Disord; 2023 Jun; 111():105399. PubMed ID: 37209484
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.
Trinh J; Hicks AA; König IR; Delcambre S; Lüth T; Schaake S; Wasner K; Ghelfi J; Borsche M; Vilariño-Güell C; Hentati F; Germer EL; Bauer P; Takanashi M; Kostić V; Lang AE; Brüggemann N; Pramstaller PP; Pichler I; Rajput A; Hattori N; Farrer MJ; Lohmann K; Weissensteiner H; May P; Klein C; Grünewald A
Brain; 2023 Jul; 146(7):2753-2765. PubMed ID: 36478228
[TBL] [Abstract][Full Text] [Related]
11. Expanding the canvas of PRKN mutations in familial and early-onset Parkinson disease.
Pandey S; Tomar LR; Kumar S; Dinesh S; Thelma BK
Parkinsonism Relat Disord; 2019 Sep; 66():216-219. PubMed ID: 31409571
[TBL] [Abstract][Full Text] [Related]
12. Rare and novel variants of PRKN and PINK1 genes in Vietnamese patients with early-onset Parkinson's disease.
Ton ND; Thuan ND; Thuong MTH; Ngoc TTB; Nhung VP; Hoa NTT; Nam NH; Dung HT; Son ND; Ba NV; Bac ND; Tai TN; Dung LTK; Hung NT; Duong NT; Ha NH; Hai NV
Mol Genet Genomic Med; 2020 Oct; 8(10):e1463. PubMed ID: 32856414
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.
González-Casacuberta I; Morén C; Juárez-Flores DL; Esteve-Codina A; Sierra C; Catalán-García M; Guitart-Mampel M; Tobías E; Milisenda JC; Pont-Sunyer C; Martí MJ; Cardellach F; Tolosa E; Artuch R; Ezquerra M; Fernández-Santiago R; Garrabou G
Neurobiol Aging; 2018 May; 65():206-216. PubMed ID: 29501959
[TBL] [Abstract][Full Text] [Related]
14. Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson's Disease.
Papagiannakis N; Liu H; Koros C; Simitsi AM; Stamelou M; Maniati M; Buena-Atienza E; Kartanou C; Karadima G; Makrythanasis P; Vatsellas G; Valente EM; Gasser T; Stefanis L
Mov Disord; 2024 Apr; 39(4):715-722. PubMed ID: 38357851
[TBL] [Abstract][Full Text] [Related]
15. The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population.
Zhao Y; Qin L; Pan H; Liu Z; Jiang L; He Y; Zeng Q; Zhou X; Zhou X; Zhou Y; Fang Z; Wang Z; Xiang Y; Yang H; Wang Y; Zhang K; Zhang R; He R; Zhou X; Zhou Z; Yang N; Liang D; Chen J; Zhang X; Zhou Y; Liu H; Deng P; Xu K; Xu K; Zhou C; Zhong J; Xu Q; Sun Q; Li B; Zhao G; Wang T; Chen L; Shang H; Liu W; Chan P; Xue Z; Wang Q; Guo L; Wang X; Xu C; Zhang Z; Chen T; Lei L; Zhang H; Wang C; Tan J; Yan X; Shen L; Jiang H; Zhang Z; Hu Z; Xia K; Yue Z; Li J; Guo J; Tang B
Brain; 2020 Jul; 143(7):2220-2234. PubMed ID: 32613234
[TBL] [Abstract][Full Text] [Related]
16. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
[TBL] [Abstract][Full Text] [Related]
17. PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants.
Clausen L; Okarmus J; Voutsinos V; Meyer M; Lindorff-Larsen K; Hartmann-Petersen R
Cell Mol Life Sci; 2024 May; 81(1):223. PubMed ID: 38767677
[TBL] [Abstract][Full Text] [Related]
18. Gene-based burden analysis of damaging private variants in PRKN, PARK7 and PINK1 in Parkinson's disease cohorts of European descent.
Hu J; Waters CH; Spiegelman D; Fon EA; Yu E; Asayesh F; Krohn L; Saini P; Alcalay RN; Hassin-Baer S; Gan-Or Z; Krainc D; Zhang B; Bustos BI; Lubbe SJ;
Neurobiol Aging; 2022 Nov; 119():136-138. PubMed ID: 36305379
[TBL] [Abstract][Full Text] [Related]
19. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
[TBL] [Abstract][Full Text] [Related]
20. Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene.
Pavan C; Jin J; Jong S; Strbenac D; Davis RL; Sue CM; Johnston J; Lynch T; Halliday G; Kirik D; Parish CL; Thompson LH; Ovchinnikov DA
Stem Cell Res; 2023 Dec; 73():103211. PubMed ID: 37890334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
